Inhibitors of Farnesyltransferase: A Rational Approach to Cancer Chemotherapy?
- 11 March 2004
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (8) , 1869-1878
- https://doi.org/10.1021/jm0305467
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Dual Protein Farnesyltransferase−Geranylgeranyltransferase-I Inhibitors as Potential Cancer Chemotherapeutic AgentsJournal of Medicinal Chemistry, 2003
- Farnesyl Transferase Inhibitors Block the Farnesylation of CENP-E and CENP-F and Alter the Association of CENP-E with the MicrotubulesJournal of Biological Chemistry, 2000
- The development of protein farnesyltransferase and other ras-directed therapeutics for malignant diseasesEmerging Drugs, 2000
- Understanding Ras: ‘it ain’t over ’til it’s over’Trends in Cell Biology, 2000
- Yeast Protein Farnesyltransferase. pKas of Peptide Substrates Bound as Zinc ThiolatesBiochemistry, 1999
- Inhibitors of protein prenylation 1999Expert Opinion on Therapeutic Patents, 1999
- Design and in Vivo Analysis of Potent Non-Thiol Inhibitors of Farnesyl Protein TransferaseJournal of Medicinal Chemistry, 1999
- Tricyclic Farnesyl Protein Transferase Inhibitors: Crystallographic and Calorimetric Studies of Structure−Activity RelationshipsJournal of Medicinal Chemistry, 1999
- H-Ras Peptide and Protein Substrates Bind Protein Farnesyltransferase as an Ionized ThiolateBiochemistry, 1998
- New approaches to anticancer drug design based on the inhibition of farnesyltransferaseDrug Discovery Today, 1998